News

A collaboration between Weill Cornell Medicine scientists and other leaders in Alzheimer’s disease research has revealed widespread metabolic changes in the brains of individuals with Alzheimer’s disease. 

An easy-to-use device for infant circumcision has proved to be safe in an international randomized controlled clinical trial led by Weill Cornell Medicine physician-scientists. The results suggest that the device could boost efforts to increase circumcision rates and prevent HIV in low-resource settings where early infant circumcision is not widespread. 

Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a landmark National Institutes of Health-funded academic project that may establish voice as a biomarker used in clinical care.

A new study by HSS Research Institute and Weill Cornell Medicine scientists identifies a mechanism by which SARS-CoV-2 induces the inflammatory response in COVID-19 patient lungs, so-called “cytokine storm”, that can lead to lasting tissue damage and poor patient outcomes.

Weill Cornell Medicine was awarded a $61.9 million grant from the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS) to continue funding its Clinical and Translational Science Center (CTSC) until 2027.

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

Dr. Gunisha Kaur, an assistant professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights, has been selected as an Emerging Leaders in Health and Medicine (ELHM) Scholar by the National Academy of Medicine.

Weill Cornell Medicine has been awarded a $1 million, three-year grant from the Department of Defense’s Kidney Cancer Research Program to fund research on the role of the protein ATF4 in clear cell renal cell carcinoma (ccRCC), a form of kidney cancer.

Awards, honors, prizes and achievements for the month of August. 

For the first time, new data shows patients with advanced heart failure who receive a heart pump can survive five years and beyond. 

A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation.

Dr. Yifan Peng, assistant professor of population health sciences at Weill Cornell Medicine, is among six Cornell faculty members who recently received National Science Foundation Faculty Early Career Development Awards.

A new study from Weill Cornell Medicine investigators shows that cultural values and social support may influence a caregiver’s burden, self-efficacy and depressive symptoms.

Dr. Anaїs Rameau, an assistant professor of otolaryngology and an attending laryngologist at the Sean Parker Institute for the Voice at Weill Cornell Medicine, has been awarded a Paul B. Beeson Emerging Leaders Career Development Award in Aging.

When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that trips these defenses, a discovery that helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity. 

Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators. 

A new preclinical study by Weill Cornell Medicine investigators found that certain bacteria in the gut may reduce susceptibility to SARS-CoV-2 infection, improve the immune response and prevent blood clots that can occur in severe COVID-19 illness.

Rana Barghout didn’t realize the power of her story until she shared it. It had been five years since she experienced homelessness, living in a car for months with her two younger siblings after a tragic house fire left her parents in the hospital. 

The discovery of how to shift damaged brain cells from a diseased state into a healthy one poses a new potential path to treating Alzheimer’s and other forms of dementia.